| Financial Year |
March 31 2023 |
| Monetary Funds |
63,581,310.20 |
| Held-for-trading Financial Assets |
5,000,000.00 |
| Notes Receivable |
9,828,428.97 |
| Accounts Receivable |
94,797,520.66 |
| Advances to Suppliers |
2,026,570.31 |
| Other Receivables |
6,261,126.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
156,752,452.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,774,826.98 |
| Total Current Assets |
345,022,236.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
13,086,525.39 |
| Investment Properties |
-- |
| Fixed Assetes |
207,340,254.63 |
| Under-construction Projects |
1,816,501.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
39,066,172.48 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
675,196.43 |
| Deferred Income Tax Assets |
14,434,018.55 |
| Other Non-Current Assets |
6,292,682.58 |
| Sub-Total of Non-Current Assets |
282,711,351.55 |
| Total Assets |
627,733,588.09 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
14,902,618.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
514,194.96 |
| Taxes Payable |
3,013,690.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
231,244.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
7,885,335.71 |
| Sub-Total of Current Liabilities |
31,895,445.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,071.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,500,916.83 |
| Total Liabilities |
39,396,362.43 |
| Paid-In Capital(Or Share Stock) |
474,000,000.00 |
| Capital Surplus |
130,744,450.70 |
| Surplus Reserve |
32,268,912.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-48,553,328.11 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
588,337,225.66 |
| Owner's Equity（Stockholder's Equity） |
588,337,225.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
627,733,588.09 |
